Cellbricks Therapeutics vs PlaqueTec
Cellbricks Therapeutics vs PlaqueTec, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellbricks Therapeutics is on 53/100 and PlaqueTec on 34/100.
Where each one leads
Cellbricks Therapeutics
- our overall score: 53/100 against 34/100
- funding raised: $7.0M against $5.0M
PlaqueTec
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Cellbricks Therapeutics | PlaqueTec |
|---|---|---|
| What it is | Biofabrication platform for 3D-printed human tissue implants and future organ manufacturing. | Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease. |
| Category | Biotechnology, Medical Devices, Regenerative Medicine, 3D Printing | Biotechnology, Medical Devices, HealthTech, Artificial Intelligence |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Headquarters | Berlin, Germany | Cambridge, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellbricks Therapeutics | PlaqueTec |
|---|---|---|
| Total funding | $7.0M | $5.0M |
| Latest round | Seed | Funding Round |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellbricks Therapeutics | PlaqueTec |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 34/100 |
| Traction | 35/100 | 33/100 |
| Team | 70/100 | Not published |
| Search visibility | 13/100 | 15/100 |
| Quality | Not published | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (44/100) |
| Domain ratingLink authority, 0-100 | Not published | 16/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellbricks Therapeutics | PlaqueTec |
|---|---|---|
| CMS | Not detected | Wix |
| Open source | No | Yes |
Cellbricks Therapeutics vs PlaqueTec: common questions
Which is better, Cellbricks Therapeutics or PlaqueTec?
On our 0-100 score Cellbricks Therapeutics rates higher (53/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Cellbricks Therapeutics and PlaqueTec compare on the numbers?
Cellbricks Therapeutics leads on our overall score (53/100 against 34/100), funding raised ($7.0M against $5.0M).
Read the full Cellbricks Therapeutics review and pricing or the PlaqueTec review and pricing. You can also browse other Cellbricks Therapeutics alternatives we track.